All treatments
Treatment
Trulicity 0.75 mg solution for injection in pre-filled pen clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
GLP-1 receptor agonists as preventive treatment of diabetes after renal transplantation: a single-arm interventional clinical trial. Study 2: Patients on the waiting list for kidney transplantation.
This study looks at whether a medicine called Trulicity can help people waiting for a kidney transplant to reverse early signs of diabetes and other health problems known as metabolic syndrome.
For: Metabolic syndrome in patients on the waiting list for kidney transplantation · Metabolic syndrome in patients on the waiting list for kidney transplantationSpain - AuthorisedTherapeutic exploratory (Phase II)
Effects of GLP-1 analogue in multiple sclerosis
This study is looking at how a specific type of medicine, usually for diabetes, might affect the brains of people with multiple sclerosis (MS). Researchers want to see if it can slow down brain changes and improve memory or thinking skills.
For: Patients with confirmed multiple sclerosis (MS) · with worse prognosis given the higher disease activity · in productive age between 18 and 60 yearsSlovakia